tirzepatide stiff neck Pain and Zepbound: What You Need to Know Does Tirzepatide Cause Headaches and

Kraemer WJ, Volek JS, French DN, Rubin MR, Sharman MJ, Gomez AL, Ratamess NA, Newton RU, Jemiolo B, Craig BW, et al

This finding positioned GLP-1 receptor agonists not merely as metabolic drugs but as cardiovascular therapeutics, a distinction that carries particular relevance for menopausal women, whose cardiovascular risk accelerates significantly during and after the transition

Despite the absence of adverse cardiovascular effects has been confirmed, this benefit was not verified in an integrated analysis of 12 controlled, randomized, short-term clinical trials (12-52 weeks) comparing exenatide with placebo or insulin [72]

Here's What We Know So Far GLP-1 medications like Ozempic and Zepbound are best known for helping with blood sugar and weight, but researchers are starting to

10.1530/JME-19-0132 J Mol Endocrinol